Novartis

NVS
Favicon Fierce Pharma

Novartis pledges nearly $480M to bolster China production, R&D

Amid a spate of pharma investments in China, Novartis is the latest drugmaker lining up to bolster its R&D and production operations in the country.
Fraiser Kansteiner Mar 23, 2026 10:35am
graphic of a larger shark chomping up a smaller one

Novartis pays $2B for breast cancer program as rivals circle

Mar 20, 2026 5:19am
phoenix rising from the flames

Atrium arises from Avidity buyout with $270M, preclinical assets

Feb 27, 2026 11:05am
Daiichi

Daiichi picks former Novartis CMO John Tsai to head up R&D

Feb 20, 2026 4:56am
Cargo shipping containers lost in ocean

Novartis jettisons ph. 1 cancer candidate after 0% efficacy

Feb 19, 2026 2:45pm
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Novartis finds natural partnership in macrocycle biotech

Feb 18, 2026 10:13am